Onkoloji Hastalarında Subklavyen ve Juguler İmplante Edilebilir Santral Venöz Portların Karşılaştırılması

Aim: Today, implantable central venous ports (ICVP) are increasingly usedin oncology patients and provide easy vascular access for delivery ofchemotherapy, other intravenous treatments, as fluids, blood products andparenteral nutrition solutions. In this study, we present our experience andcomparison of efficacy and incidence of complications between subclavianversus jugular access in oncology patients and provide easy vascular accessfor delivery of chemotherapy. Material and Method: Three hundred tenimplantable central venous ports (ICVP) were implanted via the subclavianvein (SV) in 145 patients (66 men, 79 women) with average age of 56.55(18-86) and were implanted via the external jugular vein (EJV) in 165patients (75 men, 90 women) with average age of 56.81 (19-81) betweenNovember 1,2006 and June 3, 2009. Results: There was no mortality causedby ICVP. As early complications, pneumothorax developed immediately afterthe procedure in 7 patients and arterial puncture in 34 patients. As latecomplications, infections developed in 10 patients, breakage of the catheterin one patient, malposition of catheter in one patient, jugular vein thrombosisin one patient. There was significant higher rate total implantation time inSV group (41610 catheter days) comparing with EJV group (23861 catheterdays) ( p=0.000). Discussion: According to experience, there was no differencerates of complication of catheter between the two groups despite a longerstay in SV group (complication numbers 28 in SV group, 28 in EJV group). Itshould be noted that this study took place at a single centre experience witha limited number of cases included and more research needs to be done todetermine new and better ways to long-term vascular access.